| |
 |
|
Class Information
Number: 424/93.1
Name: Drug, bio-affecting and body treating compositions > Whole live micro-organism, cell, or virus containing
Description: Subject matter involving a whole and living micro-organism, cell, or virus or its spore form.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625569 |
Yeast-based therapeutic for chronic hepatitis C infection |
Dec. 1, 2009 |
| 7622271 |
Identification of aging genes through large-scale analysis |
Nov. 24, 2009 |
| 7622124 |
Mycoplasma hyopneumoniae bacterin vaccine |
Nov. 24, 2009 |
| 7622108 |
Multi-lineage progenitor cells |
Nov. 24, 2009 |
| 7622107 |
Recombinant intracellular pathogen immunogenic compositions and methods for use |
Nov. 24, 2009 |
| 7618623 |
Hybrid adeno-retroviral vector for the transfection of cells |
Nov. 17, 2009 |
| 7618622 |
Treatment of Parkinson's disease and related disorders using postpartum derived cells |
Nov. 17, 2009 |
| 7618621 |
Mammalian multipotent neural stem cells and compositions, methods of preparation and methods of administration thereof |
Nov. 17, 2009 |
| 7618452 |
Artificially produced, three-dimensional muscle tissue |
Nov. 17, 2009 |
| 7615209 |
Compositions of NDV and methods of use thereof for treatment of cancer |
Nov. 10, 2009 |
| 7608257 |
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
Oct. 27, 2009 |
| 7608256 |
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
Oct. 27, 2009 |
| 7601530 |
Bacteria strain wenelen DSM 16786, use of said bacteria for leaching of ores or concentrates containing metallic sulfide mineral species and leaching processes based on the use of said bacteri |
Oct. 13, 2009 |
| 7601342 |
Cell fusions and methods of making and using the same |
Oct. 13, 2009 |
| 7598228 |
Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-1 |
Oct. 6, 2009 |
| 7598225 |
Generation of immune response to prostate-specific antigen (PSA) |
Oct. 6, 2009 |
| 7595303 |
Genetic adjuvants for immunotherapy |
Sep. 29, 2009 |
| 7595295 |
Use of pleiotrophin to promote neurogeneration |
Sep. 29, 2009 |
| 7592321 |
Methods of treating lysosomal storage related diseases by gene therapy |
Sep. 22, 2009 |
| 7592003 |
Regulation of toll-like receptors on stem cells |
Sep. 22, 2009 |
| 7589071 |
Large capacity viral amplicon using a minimal orilyt from human cytomegalovirus |
Sep. 15, 2009 |
| 7588771 |
Microorganisms for therapy |
Sep. 15, 2009 |
| 7588757 |
Methods of treating Parkinson's disease using recombinant adeno-associated virus virions |
Sep. 15, 2009 |
| 7585849 |
Position dependent recognition of GNN nucleotide triplets by zinc fingers |
Sep. 8, 2009 |
| 7582614 |
Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
Sep. 1, 2009 |
| 7582292 |
Adipose tissue derived stromal cells for the treatment of neurological disorders |
Sep. 1, 2009 |
| 7582289 |
Viruses for the treatment of cellular proliferative disorders |
Sep. 1, 2009 |
| 7579326 |
Gene switch systems employing regulators with decreased dimerization |
Aug. 25, 2009 |
| 7579009 |
Whole bacterial cells as immune modulator |
Aug. 25, 2009 |
| 7572438 |
Mutant having uracil phosphoribosyl transferase activity |
Aug. 11, 2009 |
| 7569681 |
Caterpiller gene family |
Aug. 4, 2009 |
| 7569219 |
Recombinant double-stranded RNA phage, and use of the same |
Aug. 4, 2009 |
| 7566459 |
Modified mycobacterium tuberculosis strains and uses thereof |
Jul. 28, 2009 |
| 7563777 |
Method to induce neovascular formation and tissue regeneration |
Jul. 21, 2009 |
| 7563776 |
Compositions comprising fusion polypeptides HIV-Nef and NGF, and methods of using the same |
Jul. 21, 2009 |
| 7563278 |
Drug-eluting intravascular prostheses and methods of use |
Jul. 21, 2009 |
| 7560280 |
Human cord blood derived unrestricted somatic stem cells (USSC) |
Jul. 14, 2009 |
| 7560102 |
Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease |
Jul. 14, 2009 |
| 7556805 |
Compositions for treatment of melanoma and method of using same |
Jul. 7, 2009 |
| 7556801 |
Human cord blood derived unrestricted somatic stem cells (USSC) |
Jul. 7, 2009 |
| 7553663 |
Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
Jun. 30, 2009 |
| 7553657 |
Substrates containing a Trichoderma asperellum strain for biological control of Fusarium and Rhizoctonia |
Jun. 30, 2009 |
| 7553641 |
Tumour necrosis factor binding ligands |
Jun. 30, 2009 |
| 7550138 |
Plasmodium mutant and vaccines including the mutant |
Jun. 23, 2009 |
| 7547682 |
Tick galectin |
Jun. 16, 2009 |
| 7544669 |
Polynucleotide therapy |
Jun. 9, 2009 |
| 7544509 |
Method for preparing stem cell preparations |
Jun. 9, 2009 |
| 7544355 |
Methods and compositions for allogeneic transplantation |
Jun. 9, 2009 |
| 7541447 |
Process for the preparation of an improved Brucella strain plasmid to develop the strain and the vaccine comprising the said strain |
Jun. 2, 2009 |
| 7541343 |
Inhibiting cellular proliferation by expressing yin yang-1 |
Jun. 2, 2009 |
|
|
|
